TXG
10x Genomics, Inc.
Stock
$93.50+4.74 (+5.34%)Close Oct 2, 2026
- Revenue, 2025
- $643M
- YoY, 2025
- +5.2%
- 5-year CAGR
- +16.6%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $643M | +5.2% |
| 2024 | $611M | −1.3% |
| 2023 | $619M | +19.8% |
| 2022 | $516M | +5.3% |
| 2021 | $490M | +64.1% |
| 2020 | $299M | +21.5% |
| 2019 | $246M | +68.1% |
| 2018 | $146M | +105.8% |
| 2017 | $71M | — |